Cargando…
An in silico analysis of rpoB mutations to affect Chlamydia trachomatis sensitivity to rifamycin
BACKGROUND: Chlamydia trachomatis is an obligate intracellular gram-negative pathogen, responsible for diverse affections, mainly trachoma and sexually transmitted diseases. Antibiotics are the commonly used drugs to tackle chlamydiae infections. However, when overused or wrongly used this may lead...
Autores principales: | Benamri, Ichrak, Azzouzi, Maryame, Moussa, Ahmed, Radouani, Fouzia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596629/ https://www.ncbi.nlm.nih.gov/pubmed/36282371 http://dx.doi.org/10.1186/s43141-022-00428-y |
Ejemplares similares
-
An overview of genes and mutations associated with Chlamydiae species’ resistance to antibiotics
por: Benamri, Ichrak, et al.
Publicado: (2021) -
Assessment of the Association of Chlamydia e pneumoniae Infection with Lung Cancer in a Moroccan Patients’ Cohort
por: Chebak, Meryem, et al.
Publicado: (2023) -
Borderline rpoB mutations transmit at the same rate as common rpoB mutations in a tuberculosis cohort in Bangladesh
por: Lempens, Pauline, et al.
Publicado: (2023) -
rpoB Mutations and Effects on Rifampin Resistance in Mycobacterium tuberculosis
por: Li, Ma-chao, et al.
Publicado: (2021) -
Detection of Mycobacterium tuberculosis in extrapulmonary biopsy samples using PCR targeting IS6110, rpoB, and nested-rpoB PCR Cloning
por: Meghdadi, Hossein, et al.
Publicado: (2015)